- Home
- ATOS vs INDO Comparison
ATOS vs INDO Comparison
Compare ATOS & INDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATOS | INDO |
|---|---|---|
| Founded | 2009 | 2018 |
| Country | United States | Indonesia |
| Employees | N/A | 31 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.3M | 68.3M |
| IPO Year | 2012 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ATOS | INDO |
|---|---|---|
| Price | $0.64 | $4.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.33 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 1.3M |
| Earning Date | 11-12-2025 | 09-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,293,625.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.55 | $2.10 |
| 52 Week High | $1.29 | $7.95 |
Technical Indicators
Market Signals| Indicator | ATOS | INDO |
|---|---|---|
| Relative Strength Index (RSI) | 46.45 | 70.28 |
| Support Level | $0.59 | $3.71 |
| Resistance Level | $0.66 | $4.95 |
| Average True Range (ATR) | 0.05 | 0.40 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 54.30 | 79.12 |
Price Performance
Historical ComparisonAbout ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.